These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17608755)

  • 1. Persisting benefits 12-18 months after discontinuation of pubertal metformin therapy in low birthweight girls.
    Ong K; de Zegher F; Valls C; Dunger DB; Ibáñez L
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):468-71. PubMed ID: 17608755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty.
    Ibáñez L; Valls C; Ong K; Dunger DB; de Zegher F
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2068-73. PubMed ID: 16492692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
    Ibáñez L; Valls C; Marcos MV; Ong K; Dunger DB; De Zegher F
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4331-7. PubMed ID: 15356029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin treatment to prevent early puberty in girls with precocious pubarche.
    Ibáñez L; Ong K; Valls C; Marcos MV; Dunger DB; de Zegher F
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2888-91. PubMed ID: 16684823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
    Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.
    Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2008 May; 93(5):1841-5. PubMed ID: 18319306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity.
    Ibáñez L; Lopez-Bermejo A; Diaz M; Marcos MV; de Zegher F
    J Pediatr; 2010 Jan; 156(1):98-102.e1. PubMed ID: 19772969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess.
    López-Bermejo A; Díaz M; Morán E; de Zegher F; Ibáñez L
    Diabetes Care; 2010 Jul; 33(7):1544-8. PubMed ID: 20357370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
    Ibáñez L; Ferrer A; Ong K; Amin R; Dunger D; de Zegher F
    J Pediatr; 2004 Jan; 144(1):23-9. PubMed ID: 14722514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early metformin therapy to delay menarche and augment height in girls with precocious pubarche.
    Ibáñez L; Lopez-Bermejo A; Diaz M; Marcos MV; de Zegher F
    Fertil Steril; 2011 Feb; 95(2):727-30. PubMed ID: 20883985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism.
    Ibáñez L; Potau N; Ferrer A; Rodriguez-Hierro F; Marcos MV; De Zegher F
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5702-5. PubMed ID: 12466374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche.
    Ibáñez L; Ong K; de Zegher F; Marcos MV; del Rio L; Dunger DB
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):372-9. PubMed ID: 12608944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Pubertal Development With Adiposity and Cardiometabolic Health in Girls and Boys-Findings From the Generation XXI Birth Cohort.
    Fonseca MJ; Oliveira A; Azevedo I; Nunes J; Santos AC
    J Adolesc Health; 2019 Oct; 65(4):558-563. PubMed ID: 31377165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment.
    Díaz M; Carreras-Badosa G; Villarroya J; Gavaldà-Navarro A; Bassols J; de Zegher F; López-Bermejo A; Villarroya F; Ibáñez L
    Pediatr Res; 2023 Mar; 93(4):964-968. PubMed ID: 35817957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
    Orbetsova M; Kamenov Z; Kolarov G; Zakharieva S; Khristov V; Atanasova I; Shigarminova R; Milcheva B; Genchev G
    Akush Ginekol (Sofiia); 2006; 45(7):16-28. PubMed ID: 17489164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
    Underdal MO; Stridsklev S; Oppen IH; Høgetveit K; Andersen MS; Vanky E
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2408-2413. PubMed ID: 29659896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.